Study screens for Type 1 

Large-scale screening for islet autoantibodies has reduced the occurrence of diabetic ketoacidosis (DKA) among children in Germany with pre-symptomatic Type 1 diabetes.  

The screening, part of a research study called Fr1da, tested 90,632 children aged 2–5 in Bavaria, during primary care visits. Over four years, 280 children showed pre-symptomatic Type 1 diabetes (.31%), of which 24.9% developed the condition, and the prevalence of DKA was less than 5% – in unscreened children, DKA prevalence is 20% in Germany.  

Fr1da, led by Anette-Gabriele Ziegler, Director of the Institute of Diabetes Research at Helmholtz Zentrum München, shows that large-scale screenings are possible and that there can be benefits to early diagnosis of Type 1 diabetes.  

“A potential clinical benefit of identifying Type 1 diabetes in a pre-symptomatic stage is a reduction in the prevalence of life-threatening diabetic ketoacidosis,” explains Ziegler.  

Next steps involve a cost-benefit analysis of the screenings, which could further support the inclusion of screenings for pre-symptomatic Type 1 diabetes into standard care. “Early diagnosis would make the road to a world without Type 1 diabetes much easier,” Ziegler said.   

  • Read the original research in JAMA  and watch this youTube video for more information. 


Desang Diabetes Magazine is our free-to-receive digital journal (see below). We cover diabetes news, diabetes management equipment (diabetes ‘kit’ such as insulin pumps and continuous glucose monitoring equipment) and news about food suitable for a diabetic diet including a regular Making Carbs Count column. We just need your email address to subscribe you (it really is free, and you can easily unsubscribe should you wish to).

Sign me up!
Open publication
Buy a Desang kitbag

See our range of kitbags